LAHORE: The Drug Regulatory Authority of Pakistan (DRAP) has finally
fixed price of the ‘blockbuster’ oral drug - Sovaldi – after its
registration in Pakistan, giving a good news to hepatitis C patients.
decision was taken in a meeting of DRAP’s Drug Price Committee presided
over by Pricing Director Mr Amanullah in Islamabad on Thursday, a
senior official in the authority told Dawn.
He said the Ferozsons
Laboratories is the sole company which was granted rights to sell and
market this much-awaited drug in Pakistan at a price approximately
Rs1,940 for each tablet. The company will make available a pack of 28
tablets for total price Rs55,000 [$890 US] after final approval by the federal
While highlighting the
significance of the new life-saving drug, Technical Advisory Group (TAG)
Member Prof Dr Ghiasun Nabi Tayab said presently approximately 10
million people in the country were living with chronic hepatitis C virus
Labels: Pakistan, pricing, Sovaldi